WHO ICTRP trial
A Phase 3 trial to assess efficacy and safety of Mycobacterium tuberculosis…
PACTR202401850967550 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202401850967550 |
|---|---|
| Public title | A Phase 3 trial to assess efficacy and safety of Mycobacterium tuberculosis (Mtb) vaccine in adolescents and adults. |
| Scientific title | A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of the investigational M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered intramuscularly on a 0,1-month schedule to adolescents… |
| Primary sponsor | Bill and Melinda GatesMedical Research Institute |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-3 |
| Countries | Malawi;Malawi;Mozambique;Zambia;Zambia;Zambia;Zambia;Kenya;Kenya;Kenya;Kenya;Kenya;Kenya;Kenya;Kenya;Kenya;South Africa;South Africa;South Africa;South Africa;South Africa;South Africa;South… |
| Conditions | Tuberculosis |
| Registration date | Jul 25, 2023 |
| Target size | 26000 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: